- Report
- October 2024
- 192 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 182 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 198 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 189 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 183 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 186 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 191 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 180 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 190 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 186 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- April 2025
- 200 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 145 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- April 2025
- 138 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- February 2025
- 150 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- February 2025
- 147 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- January 2025
- 136 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- August 2024
- 149 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- August 2024
- 147 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- August 2024
- 145 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- August 2024
- 147 Pages
Global
From €2730EUR$2,999USD£2,318GBP

The RNA market is a subset of the genomics market that focuses on the study of ribonucleic acid (RNA). RNA is a molecule that plays a key role in the regulation of gene expression and is involved in many cellular processes. It is used in a variety of applications, including diagnostics, therapeutics, and research.
The RNA market is expected to grow at a steady rate due to the increasing demand for RNA-based products and services. This growth is driven by advances in technology, such as next-generation sequencing, which has enabled the development of more accurate and cost-effective RNA-based products. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine are expected to drive the growth of the RNA market.
Companies in the RNA market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, Bio-Rad Laboratories, and F. Hoffmann-La Roche. Show Less Read more